 Connection
Curtis Coughlin II to Neonatal Screening
This is a "connection" page, showing publications Curtis Coughlin II has written about Neonatal Screening.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
2.028 |
|
|
|
-
Pauly K, Woontner M, Abdenur JE, Chaudhari BP, Gosselin R, Kripps KA, Thomas JA, Wempe MF, Gospe SM, Coughlin CR. Feasibility of newborn screening for pyridoxine-dependent epilepsy. Mol Genet Metab. 2025 Jan; 144(1):109002.
Score: 0.784
-
Coughlin CR, Tseng LA, van Karnebeek CDM. A case for newborn screening for pyridoxine-dependent epilepsy. Cold Spring Harb Mol Case Stud. 2022 02; 8(2).
Score: 0.649
-
Wempe MF, Kumar A, Kumar V, Choi YJ, Swanson MA, Friederich MW, Hyland K, Yue WW, Van Hove JLK, Coughlin CR. Identification of a novel biomarker for pyridoxine-dependent epilepsy: Implications for newborn screening. J Inherit Metab Dis. 2019 05; 42(3):565-574.
Score: 0.526
-
Ficicioglu C, Coughlin CR, Bennett MJ, Yudkoff M. Very long-chain acyl-CoA dehydrogenase deficiency in a patient with normal newborn screening by tandem mass spectrometry. J Pediatr. 2010 Mar; 156(3):492-4.
Score: 0.070
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|